Australia’s Wellnex Cashes Up For Script-Free CBD

Australian health and wellness product company Wellnex Life Limited (ASX: WNX), has announced the amount raised under a recent share placement plan and private placement came to a total of $5.965 million.

In July this year, Wellnex formed a joint venture with Melbourne-based medical cannabis firm OneLife Botanicals to bring  registered medicinal cannabis and hemp-based products to Australian and international markets. Just the week prior, OneLife had inked an agreement with Canada-headquartered cannabinoid company MediPharm Labs Corp. for the sale of MediPharm Labs Australia.

OneLife completed acquisition of MediPharm Labs Australia early this month.